The American College of Radiology and the Colon Cancer Alliance call on Congress to pass HR 4165, which would cover CT colonography screening under Medicare.
The American College of Radiology and the Colon Cancer Alliance are calling on Congress to pass a bill that would cover Medicare beneficiaries for CT colonography screening.
H.R. 4165, the CT Colonography Screening for Colorectal Cancer Act, would provide seniors access to virtual colonoscopies, which can boost screening rates and save lives, the groups said. The bill was introduced in March, and also unsuccessfully introduced two years ago.
“Congress has been given a chance to make a difference in the lives of many Americans. I hope lawmakers act now and support the passage of H.R. 4165,” Andrew Spiegel, chief executive officer of the Colon Cancer Alliance, said in a statement.
In 2009, CMS indicated that routine CT colonography would not be covered because of a lack of information supporting its effectiveness. However, a recent study published in the American Journal of Roentgenology found colonography screening compliance could be increased by 15 percent if covered by Medicare or third-party payers.
CT colonography uses low-dose X-rays to produce 3D moving images of the colon. The virtual exam is far less invasive than standard colonoscopy and doesn’t require sedation, according to the ACR. The test is also safer for those Americans with underlying medical problems.
“The American College of Radiology has made significant strides in the fight to make virtual colonoscopy a reality for America’s seniors. The exam is now endorsed by the American Cancer Society as a recommended screening test, and major insurers, including CIGNA, UnitedHealthcare and Anthem Blue Cross Blue Shield, now cover it,” said Paul H. Ellenbogen, MD, chair of the ACR Board of Chancellors. “The college encourages Congress and lawmakers to support Medicare coverage of virtual colonoscopy and pass H.R. 4165.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.